CME Q3 deep dive: diversified volume growth and product innovation underpin results

Financial derivatives exchange CME Group (NASDAQ:CME) announced better-than-expected revenue in Q3 2026, with sales up 13% year on year to $1.74 billion. Its non-GAAP profit of $3.02 per share was 1% above analysts’ consensus estimates.

Is now the time to buy CME? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

CME Group’s third quarter was marked by robust volume growth across all six asset classes, as management cited shifting central bank policies, geopolitical uncertainty, and persistent market volatility as primary catalysts for heightened client activity. CEO Terry Duffy emphasized that average daily volume reached a new third-quarter record, with international markets showing notable strength. The company highlighted continued momentum in market data services and capital efficiencies for customers, supporting its above-consensus revenue and profit despite a lack of significant market reaction to the results.

Looking forward, CME Group’s leadership pointed to ongoing product innovation, regulatory-driven changes in Treasury clearing, and a focus on expanding 24/7 trading as central to its strategy. Duffy stated, “Innovation will continue to be a key driver of our performance and our ability to serve our clients effectively,” while also acknowledging the importance of maintaining market integrity and client protection. The migration to cloud infrastructure and the rollout of new offerings such as Single Stock futures and Compute Futures are expected to shape the company’s trajectory over the coming quarters.

Key insights from management’s remarks

Management attributed the strong third quarter to broad-based growth in trading activity, the launch of new products, and deeper engagement across its global client base.

• International volume acceleration: International average daily volume rose 22% year-over-year, led by 40% growth in energy products, 28% in agricultural products, and 24% in equity index products, reflecting increased demand for CME's risk management tools outside the U.S.
• Product launch momentum: Several new products, including Single Stock futures and E-nano Equity Index futures, were introduced, with Single Stock futures quickly gaining traction among both institutional and retail clients, and providing new margin efficiency opportunities.
• Market data revenue milestones: Market data revenue set an all-time quarterly record, driven by a broader subscriber base across professional, retail, and simulation platforms, as well as increased demand for real-time pricing and data feeds amid global volatility.
• Capital efficiency gains: Customers saved over $100 billion a day in margin requirements, with growth in cross-margining programs, especially in swap and equity products, and new portfolio margining participants using CME to optimize capital usage.
• 24/7 trading expansion: Building on the initial success of around-the-clock trading in gold, silver, and cryptocurrencies, CME expanded 24/7 access to additional contracts and is exploring further asset classes, though regulatory and infrastructure challenges remain for larger markets.

Drivers of future performance

CME Group expects continued product innovation, regulatory changes, and infrastructure modernization to drive volume and margin performance in the near and medium term.

• Regulatory-driven opportunities: The upcoming Treasury clearing mandate is anticipated to boost demand for CME’s clearing services and related products, with the launch of CME Securities Clearing positioned to capture new client flows tied to regulatory changes.
• Product and technology expansion: Management is focused on launching new products such as Compute Futures and expanding the 24/7 trading model, while also progressing with the Google Cloud migration to offer clients greater flexibility and reliability.
• Market structure shifts: Changes in client risk management needs, fueled by volatility, AI infrastructure growth, and evolving trading behaviors, are expected to support ongoing volume growth, though management cautioned that full realization of some initiatives depends on regulatory approval and broader market infrastructure changes.

Catalysts in upcoming quarters

In the coming quarters, the StockStory analyst team will watch closely for (1) regulatory developments impacting Compute Futures and the Treasury clearing mandate, (2) uptake and client engagement with new products such as Single Stock futures and 24/7 trading contracts, and (3) measurable progress in the migration to Google Cloud infrastructure. The pace of growth in capital efficiency programs and international expansion will also be important signposts.

CME Group currently trades at $296.14, in line with $295.31 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

Stocks that trumped tariffs

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.